$CTIC CTI BIOPHARMA CORP Insider Trading Week 11/2014

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in CTI BIOPHARMA CORP.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in CTI BIOPHARMA CORP in week 11/2014.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	BIANCO JAMES A	President and CEO	Sell	S	3.79	145,000	548,825	2,402,794	2.5 M to 2.4 M (-5.69 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	BIANCO JAMES A	President and CEO	Sell	S	3.86	250,000	965,500	2,547,794	2.8 M to 2.5 M (-8.94 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	3.82	9,906	37,841	822,897	832.8 K to 822.9 K (-1.19 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	3.81	23,276	88,682	832,803	856.1 K to 832.8 K (-2.72 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	BIANCO LOUIS A	EVP, Finance & Admi ...	Sell	S	3.80	91,818	348,908	856,079	947.9 K to 856.1 K (-9.69 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.76	1,000	3,755	620,904	621.9 K to 620.9 K (-0.16 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.75	1,100	4,127	621,904	623 K to 621.9 K (-0.18 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.75	300	1,125	623,004	623.3 K to 623 K (-0.05 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.75	200	750	623,304	623.5 K to 623.3 K (-0.03 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.75	300	1,124	623,504	623.8 K to 623.5 K (-0.05 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.75	100	375	623,804	623.9 K to 623.8 K (-0.02 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.75	14,000	52,430	623,904	637.9 K to 623.9 K (-2.19 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.74	400	1,497	637,904	638.3 K to 637.9 K (-0.06 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.74	9,000	33,660	638,304	647.3 K to 638.3 K (-1.39 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.74	100	374	647,304	647.4 K to 647.3 K (-0.02 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.74	10,800	40,338	647,404	658.2 K to 647.4 K (-1.64 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.73	1,400	5,225	658,204	659.6 K to 658.2 K (-0.21 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.73	400	1,492	659,604	660 K to 659.6 K (-0.06 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.73	18,600	69,378	660,004	678.6 K to 660 K (-2.74 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.73	22,086	82,270	678,604	700.7 K to 678.6 K (-3.15 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.72	300	1,117	700,690	701 K to 700.7 K (-0.04 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.72	2,500	9,303	700,990	703.5 K to 701 K (-0.36 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.72	68,656	255,400	703,490	772.1 K to 703.5 K (-8.89 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.72	10,158	37,737	772,146	782.3 K to 772.1 K (-1.30 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.71	600	2,227	782,304	782.9 K to 782.3 K (-0.08 %)
Mar 21 2014	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	3.71	8,000	29,680	782,904	790.9 K to 782.9 K (-1.01 %)